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Breast-feeding is a known protective factor against breast cancer. Breast-feeding duration is influenced by hormone
levels, milk production, and lifestyle factors. The aims were to investigate how breast-feeding duration and milk
production affected tumor characteristics and risk for early breast cancer events in primary breast cancer patients.
Between 2002 and 2008, 634 breast cancer patients in Lund, Sweden, took part in an ongoing prospective cohort
study. Data were extracted from questionnaires, pathology reports, and patients’ charts from 592 patients without
preoperative treatment. Breast-feeding duration ≤12 months of the first child was associated with higher frequency
of ER+/PgR+ tumors (P=0.02). Median follow-up time was 4.9 years. Higher risk for early events was observed for
breast-feeding duration of first child >12 months (LogRank P=0.001), total breast-feeding duration >12 months
(LogRank P=0.008), as well as ‘excessive milk production’ during breast-feeding of the first child (LogRank P=0.001).
Patients with ‘almost no milk production’ had no events. In a multivariable model including both ‘excessive milk
production’ and breast-feeding duration of the first child >12 months, both were associated with a two-fold risk for
early events, adjusted HRs 2.33 (95% CI: 1.25-4.36) and 2.39 (0.97-5.85), respectively, while total breast-feeding
duration was not. ‘Excessive milk production’ was associated with a two-fold risk of early distant metastases,
adjusted HR 2.59 (1.13-5.94), but not duration. In conclusion, ‘excessive milk production’ during breast-feeding was
associated with higher risk for early events independent of tumor characteristics, stressing the need to consider
host factors in the evaluation of prognostic markers.
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Breast cancer is the most common type of cancer among
women in Sweden with nearly 8000 cases reported every
year (The National Board of Health and Welfare 2011a).
Breast cancer specific mortality is approximately 1500
women per year in Sweden (The National Board of Health
and Welfare 2011b). Risk factors that influence the
incidence of breast cancer may also affect survival
after diagnosis (Barnett et al. 2008). Increased under-
standing of how lifestyle factors affect prognosis and
tumor characteristics may contribute to better
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in any medium, provided the original work is pData from >50 000 breast cancer cases and >95 000
controls reveal that each year of breast-feeding de-
creases the risk by 4.3% (Collaborative Group on
Hormonal Factors in Breast Cancer 2002), while
others reported no overall association between breast-
feeding and breast cancer (Michels et al. 1996). In
women with BRCA1 mutations, one year of breast-
feeding was associated with between 32% and 45% de-
crease in the risk (Jernström et al. 2004; Kotsopoulos
et al. 2012). Shorter breast-feeding duration has been
associated with several factors such as BRCA1 mutations
(Jernström et al. 1998), body mass index (BMI) >30
(Guelinckx et al. 2011), and smoking (Hietala et al. 2008;
Donath & Amir 2004). Low milk production has been asso-
ciated with shorter duration of breast-feeding (Hietala et al.
2008; Gatti 2008). Whether insufficient milk production isan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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to a review (Cohen et al. 2009). A murine model has sug-
gested a link between breast tumor cells and insufficient
maternal milk supply (Cohen et al. 2009; Lazar et al. 2000).
The protective effect of breast-feeding, in high-risk BRCA1
mutation carriers as well as women in general, is thought
to be mediated in part by the decrease in post-lactational
prolactin levels (Hietala et al. 2008), as well as a decrease in
free testosterone levels (Nagata et al. 2011). One study
showed that post-lactational prolactin levels were deter-
mined by breast-feeding duration of the first child and not
simply by the first full-term pregnancy (Hietala et al. 2008).
Additional pregnancies and prolonged total breast-feeding
duration did not seem to further lower the hormonal levels
(Hietala et al. 2008; Nagata et al. 2011). Women who
reported insufficient milk production had higher prolactin
levels (Hietala et al. 2008). The effect of milk production
per se as opposed to breast-feeding duration on breast can-
cer is unknown. Prolactin increases the risk of breast cancer
(Tworoger et al. 2007) and can promote cell proliferation
and survival, increase cell motility, and support tumor
vascularization (Tworoger & Hankinson 2006). However, in
breast cancer cells, prolactin has also been implicated as an
invasion suppressor hormone (Nouhi et al. 2006).
According to two previous studies, there was no association
between total breast-feeding duration and breast cancer
survival (Trivers et al. 2007; Alsaker et al. 2011). To our
knowledge, the effect of milk production on breast cancer-
free survival has not been previously studied.
The breast is a dynamic tissue that develops
throughout pregnancy, childbirth and lactation (Ged-
des 2007). Breast-feeding affects the lobulo-alveolar
breast tissue and is associated with fewer type 1 lob-
ules, which are rich in ER+ receptors (Russo et al.
2000). ER+ tumors grow more slowly and relapse
later than ER– tumors (Osborne et al. 1980). The as-
sociation between milk production and tumor charac-
teristics or prognosis of women who subsequently
develop breast cancer are unclear. Some studies have
addressed the association between tumor characteris-
tics and breast-feeding duration. Three studies
reported that long breast-feeding was rare in patients
with ER-/PgR- breast cancer (Palmer et al. 2011), or
with triple negative breast cancer (Redondo et al.
2012; Gaudet et al. 2011). Others reported that longer
breast-feeding was associated with reduced risk of
basal-like breast cancer (Millikan et al. 2008), or that
breast-feeding was a protective factor for luminal sub-
type when compared to non-luminal breast cancer
(Turkoz et al. 2013).
The aims of the study were to investigate whether
breast-feeding duration and milk production were as-
sociated with the tumor characteristics and prognosis
of women who subsequently developed breast cancer.Material and methods
Between October 2002 and October 2008, women diag-
nosed with a first breast cancer at Skåne University Hos-
pital in Lund, Sweden were invited to participate in an
ongoing prospective study that focuses on how lifestyle
factors influence prognosis and treatment response. Pa-
tients that had been treated for another cancer during
the last 10 years were excluded. The study was approved
by the Lund University Ethics Committee (Dnr LU75-02
& LU37-08). All participating patients signed informed
consents. Six hundred and thirty four patients were in-
cluded in the study during this period. Forty-two were
excluded because of pre-operative treatment that may
have affected tumor characteristics, leaving 592 pre-
operatively untreated women. The follow-up rates of the
patients without preoperative treatment who were alive
and breast cancer-free were as follows for the 9, 7, 5,
and 3-year: 80.0, 86.3, 92.6, and 93.5 %, respectively. An-
other 89 women were nulliparous and were excluded
from the analyses regarding breast-feeding and milk
production.
Patients received a pre-operative questionnaire on life-
style and reproductive factors. The question regarding
the duration of breast-feeding of each child was open.
When the patient responded with an interval (e.g. 3–5
months), the highest value was used. In case of twins,
only breast-feeding duration for one child was used. In
regards to milk production for each child, the women
were asked to pick between four alternatives: ‘almost no
milk’, ‘insufficient’, ‘adequate’ or ‘excessive’. There was no
question as to why a woman stopped breast-feeding.
The question about smoking habits enquired whether
the patients were currently smoking regularly, occasion-
ally at parties, or not at all. A trained research nurse
took body measurements, including weight, height,
breast volume, and hip- and waist circumference. The
nurse measured the volume of each breast, as previously
described (Ringberg et al. 2006). After 3–6 months, 1, 2,
3, 5, 7, and 9 years, the patients received follow-up
questionnaires.
Tumor characteristics were retrieved from pathology
reports and included invasive tumor size, number of ax-
illary lymph nodes involved, distant metastases and
histologic grade. The expression of hormone receptors
ER and PgR were analyzed. Tumors with >10% positive
nuclear staining, were considered receptor positive
(Bågeman et al. 2008; Jernström et al. 2009). Survival
status and date of death were collected from the Swedish
Population Registry. Clinical data including breast can-
cer events were obtained from patients’ charts.
Statistics
SPSS Statistics 19 (IBM, Chicago, IL, USA) was used to
analyze the data. Certain factors were not normally
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vals, 1903–1940, 1941–1954 and 1955+, due to differing
patterns of breast-feeding over time (The National Board
of Health and Welfare 2010). Age at diagnosis was di-
chotomized, younger than 50 years versus 50 years and
older and was also used as a proxy variable for meno-
pause. It was not possible determine the exact age of
menopause in patients who reported previous hormone
therapy use and had hormone induced bleedings as well
as in patients who reported hysterectomies without
oophorectomies.
Breast-feeding duration of the first child was dichoto-
mized into two groups, with the cut-point ≤12 months.
Total breast-feeding duration for all children was also
dichotomized, with the cut-point ≤12 months. Milk pro-
duction was analyzed as a categorical variable including
‘almost no milk’, ‘insufficient, ‘adequate’ or ‘excessive’.
The Chi-square test was used to analyze breast-feeding
and milk production in relation to categorized variables.
Reproductive factors included parity, age at first birth,
breast-feeding duration, and amount of milk production
for each child. Parity was classified as; 0, 1, 2, ≥3 chil-
dren. Age at first birth was divided into four groups;
<20, 20–24, 25–29, and ≥30 years.
BMI was stratified according to <25 kg/m2 (yes/no).
Waist Hip Ratio (WHR) was defined as ≤0.85 (yes/no)
(World Health Organization 2006; World Health
Organization 2008). Breast volume was dichotomized as
<850 ml or ≥850 ml (Markkula et al. 2012). Current
smoking was defined as ‘yes’ or ‘no’. Women who
reported smoking occasionally at parties were classified
as smokers.
Disease-free survival was defined as absence of breast
cancer events until the day of the last study follow-up or
death, before January 1st, 2012. An event was classified
as the occurrence of new breast cancer, local recurrence,
regional or distant metastases. Patients with carcinoma
in situ (n = 14) or a breast cancer event before three
months after inclusion in study (n = 2) were excluded
from the survival analyses. After excluding these patients
and nulliparous patients, there were 64 breast cancer
events including 39 distant metastases.
Survival in relation to breast-feeding duration >12
months (yes/no) and milk production for the first child
‘excessive’ (yes/no) was analyzed using Kaplan-Meier
Log-Rank tests. Adjusted Hazard Ratios (HR) were ana-
lyzed using Cox regression. Adjustments were made for
invasive tumor size (>20mm or muscular or skin in-
volvement), any axillary lymph node involvement, ER
and PgR status (positive/negative), and age (continuous),
age at first full-term pregnancy (continuous), time since
last full-term pregnancy (continuous), current smoking
(yes/no), BMI <25 kg/m2 (yes/no), type of surgery in-
cluding any reoperation modified radical mastectomy(yes/no), and treatment; tamoxifen (yes/no), aromatase
inhibitor (yes/no), chemotherapy (yes/no), radiation
therapy (yes/no).
The P-values were two-tailed and considered signifi-
cant when <0.05. Nominal P-values were presented with-
out adjustment for multiple testing.
Results
Patient characteristics
Characteristics of the 592 patients, regarding breast-
feeding duration and milk production, are presented in
Tables 1 and 2. The median value for year of birth for all
women was 1945 (range 1903 to 1977). The median age
of diagnosis was 59.9 years (range 25.8 to 99.9). As
presented in Table 1, a significantly higher median age at
first birth was seen among the women who had breast-
fed their first child >12 months (P=0.02), compared to
women with shorter breast-feeding duration, 29 years
versus 24 years, respectively. The group of patients with
a total breast-feeding duration of >12 months had a sig-
nificantly lower percent of current smokers compared to
the group with a total breast-feeding duration of ≤12
months (P=0.004). The median time since first preg-
nancy was 35.6 (range 0.8 to 80.9) years and the median
time since last pregnancy was 30.9 (range 0.8 to 70.9)
years.
As presented in Table 2, a lower age at diagnosis was
significantly associated with a greater milk production
(Ptrend=0.004). Milk production was not associated with
other patient characteristics. Both longer breast-feeding
duration of the first child and longer total breast-feeding
duration were significantly associated with greater milk
production while breast-feeding the first child
(Ptrend=0.001) and (Ptrend<0.0001), respectively.
Tumor characteristics
Table 3 presents the tumor characteristics of the 592 pa-
tients, in relation to breast-feeding duration. Shorter
breast-feeding duration of the first child was associated
with a higher frequency of ER+/PgR+ tumors (P=0.02).
There was also a significant association between PgR+
tumors and shorter breast-feeding duration of the first
child (P=0.02). ER–/PgR– tumors were more common
among women who had breast-fed their first child >12
months, but this was not significant (P=0.09). The num-
ber of axillary lymph nodes involved was non-
significantly higher among patients who had breast-fed
their first child >12 months (Ptrend=0.09). Milk produc-
tion was not associated with tumor characteristics,
Table 4.
Risk for early breast cancer events
Risk for early breast cancer events was analyzed in rela-
tion to breast-feeding duration of the first child
Table 1 Patient characteristics in relation to self-reported breast-feeding duration
Table 1 Allpatients Nulliparous
Breastfeeding duration of
first child ≤12 months
Breastfeeding duration of









n=592 n=89 n=476 n=20 n=325 n=178
n
(percent) n (percent) n (percent) n (percent) n (percent) n (percent)
Year of birth
1903-1940 171 (28.9%) 24 (27%) 14 (29.8%) 4 (20.0%) 95 (29.2%) 52 (29.2%)
1941-1954 286 (48.3%) 47 (52.8%) 224 (47.1%) 10 (50.0%) 0.31 162 (49.8%) 77 (43.3%) 0.31
1955+ 135 (22.8%) 18 (20.2%) 110 (23.1%) 6 (30.0%) 68 (20.9%) 49 (27.5%)
Age at diagnosis (years)
<50 120 (20.3%) 17 (19.1%) 98 (20.6%) 4 (20.0%) 1df; 0.95 63 (19.4%) 40 (22.5%) 1df; 0.41
≥50 472 (79.7%) 72 (80.9%) 378 (79.4%) 16 (80.0%) 262 (80.6%) 138 (77.5%)
Body Mass Index (BMI), (kg/m-
2)
<25 312 (53.0%) 51 (57.3%) 244 (51.6%) 13 (65.0%) 167 (51.5%) 94 (53.4%)
≥25-<30 182 (30.9%) 22 (24.7%) 154 (32.6%) 4 (20.0%) 0.40 106 (32.7%) 54 (30.7%) 0.81
≥30 95 (16.1%) 16 (18.0%) 75 (15.9%) 3 (15.0%) 51 (15.7%) 28 (15.9%)
Missing 3 0 3 0 0 2
Waist-Hip-Ratio (WHR)
≤0,85 340 (57.6%) 51 (58.0%) 274 (57.7%) 11 (55.0%) 1df;0.81 183 (56.5%) 106 (59.6%) 1df; 0.51
>0,85 250 (42.4%) 37 (42.0%) 201 (42.3%) 9 (45.0%) 141 (43.5%) 72 (40.4%)
Missing 2 1 1 0 1 0
Breast volume (ml)
<850 219 (37.0%) 33 (37.1%) 176 (37.0%) 8 (40.0%) 1df; 0.86 120 (36.9%) 66 (37.1%) 1df; 0.42
≥850 292 (49.3%) 40 (45.0%) 239 (50.2%) 10 (50.0%) 153 (47.1%) 99 (55.6%)
Missing* 81 16 61 2 52 13
Current smoking
Yes 130 (22%) 24 (27.0%) 101 (21.2%) 2 (10.0%) 1df; 0.23 81 (24.9%) 25 (14.0%) 1df; 0.004
No 462 (78%) 65 (73.0%) 375 (78.8%) 18 (90.0%) 244 (75.1%) 153 (86.0%)
Parity
0 89 (15.0%) 89 (100%) 0 0 0 0
1 91 (15.4%) 84 (17.6%) 6 (30.0%) 85 (26.2%) 6 (3.4%)
2 253 (42.7%) 240 (50.4%) 10 (50.0%) 0.12 186 (57.2%) 67 (37.6%) <0.0001















Table 1 Patient characteristics in relation to self-reported breast-feeding duration (Continued)
Age at first birth, years**
<20 62 (12.4%) 59 (12.4%) 3 (10.0%) 43 (13.3%) 19 (10.8%)
20-24 187 (37.4%) 179 (37.8%) 5 (25.0%) 0.03 130 (40.1%) 57 (32.4%) 0.08
25-29 175 (35.0%) 168 (35.4%) 5 (25.0%) 104 (32.1%) 71 (40.3%)
30+ 76 (15.2%) 68 (14.3%) 8 (40.0%) 47 (14.5%) 29 (16.5%)
Missing 3 2 0 1 2
Milk production of first child **
Almost no milk 25 (5.2%) 24 (5.3%) 0 23 (7.5%) 2 (1.2%)
Too little milk 129 (27.0%) 128 (28.3%) 0 106 (34.5%) 23 (13.5%)
Adequate amount of milk 245 (51.3%) 229 (50.6%) 13 (65.0%) 0.001 137 (44.6%) 108 (63.2%) <0.0001
Too much milk 79 (16.5%) 72 (15.9%) 7 (35.0%) 41 (13.4%) 38 (22.2%)
Missing 25 23 0 18 7
* Data missing or previous breast surgery.



















Milk production of first
child -Almost no milk
Milk production of first
child -Insufficient
Milk production of first
child -Adequate
Milk production of first
child -Excessive Ptrend
n=592 n=89 n=25 n=129 n=245 n=79
n (percent) n (percent) n (percent) n (percent) n (percent) n (percent)
Year of birth
1903-1940 171 (28.9%) 24 (27.0%) 7 (28.0%) 35 (27.1%) 76 (31.0%) 21 (26.6%) 0.16
1941-1954 286 (48.3%) 47 (52.8%) 16 (64.0%) 69 (53.5%) 109 (44.5%) 34 (43.0%)
1955+ 135 (22.8%) 18 (20.2%) 2 (8.0%) 25 (19.4%) 60 (24.5%) 24 (30.4%)
Age at diagnosis (years)
<50 120 (20.3%) 17 (19.1%) 1 (4.0%) 22 (17.1%) 52 (21.2%) 23 (29.1%) 0.004
≥50 472 (79.7%) 72 (80.9%) 24 (96.0%) 107 (82.9%) 193 (78.8%) 56 (70.9%)
Body Mass Index (BMI), (kg/m-2)
<25 312 (53.0%) 51 (57.3%) 8 (32.0%) 62 (48.4%) 138 (56.3%) 41 (53.2%) 0.074
≥25-<30 185 (30.9%) 22 (24.7%) 8 (32.0%) 51 (39.8%) 68 (27.8%) 25 (32.5%)
≥30 95 (16.1%) 16 (18.0%) 9 (36.0%) 15 (11.7%) 39 (15.9%) 11 (14.3%)
Missing 3 0 0 1 0 2
Waist-Hip-Ratio (WHR)
≤0,85 340 (57.6%) 51 (58.0%) 12 (48.0%) 75 (58.1%) 146 (59.8%) 43 (54.4%) 0.82
>0,85 250 (42.4%) 37 (42.0%) 13 (53.0%) 54 (41.9%) 98 (40.2%) 36 (45.6%)
Missing 2 1 0 0 1 0
Breast volume (ml)
<850 219 (37.0%) 33 (37.1%) 6 (24.0%) 54 (41.9%) 97 (39.6%) 20 (25.3%) 0.19
≥850 292 (49.3%) 40 (44.9%) 15 (60.0%) 58 (45.0%) 116 (47.3%) 50 (63.3%)
Missing* 81 16 4 17 32 9
Current smoking 0.19
Yes 130 (22%) 24 (27.0%) 9 (36.0%) 27 (20.9%) 44 (18.0%) 16 (20.3%)
No 462 (78%) 65 (73.0%) 16 (64.0%) 102 (79.1%) 201 (82.0%) 63 (79.7%)
Missing 0 0 0 0 0 0
Parity
0 89 (15.0%) 89 (100%) 0 0 0 0 0.43
1 91 (15.4%) 3 (12.0%) 22 (17.1%) 47 (19.2%) 15 (19.0%)
2 253 (42.7%) 14 (56.0%) 64 (49.6%) 125 (51.0%) 40 (50.6%)
3+ 159 (26.9%) 8 (32.0%) 43 (33.3%) 73 (29.8%) 24 (30.4%)















Table 2 Patient characteristics in relation to self-reported milk production of the first child (Continued)
Age at first birth, years**
<20 62 (12.4%) 5 (20.0%) 16 (12.4%) 26 (10.7%) 10 (12.7%) 0.09
20-24 187 (37.4%) 8 (32.0%) 59 (45.7%) 73 (30.0%) 35 (44.3%)
25-29 175 (35.0%) 11 (44.0%) 44 (34.1%) 93 (38.3%) 23 (29.1%)
30+ 76 (15.2%) 1 (4.0%) 10 (7.8%) 51 (21.0%) 11 (13.9%)
Missing 3 0 0 2 0
Breastfeeding duration of first child**
Breastfeeding duration of first child, ≤ 12 months 476 (96.0%) 24 (100%) 128 (100%) 229 (94.6%) 72 (91.1%) 0.001
Breastfeeding duration of first child, > 12 months 20 (4%) 0 (%) 0 (%) 13 (5.4%) 7 (8.9%)
Missing 7 1 1 3 0
* Data missing or previous breast surgery.















Table 3 Tumor characteristics in relation to self-reported breast-feeding duration
Table 3 Allpatients Nulliparous
Breastfeeding duration of
first child ≤12 months
Breastfeeding duration of









n=592 n=89 n=476 n=20 n=325 n=178
n (percent) n (percent) n (percent) n (percent) n (percent) n (percent)
pT
0 14 (2.4%) 3 (3.4%) 10 (2.1%) 0 9 (2.8%) 2 (1.1%)
1 424 (71.6%) 61 (68.5%) 347 (72.9%) 12 (60.0%) 237 (72.9%) 126 (70.8%)
2 144 (24.3%) 23 (25.8%) 111 (23.3%) 8 (40.0%) 0.20 72 (22.2%) 49 (27.5%) 0.47
3 9 (1.5%) 2 (2.2%) 7 (1.5%) 0 6 (1.8%) 1 (0.6%)
4 1 (0.2%) 0 1 (0.2%) 0 1 (0.3%) 0
Number of axillary lymph
nodes
0 368 (62.4%) 61 (68.5%) 296 (62.3%) 9 (47.4%) 203 (62.7%) 104 (58.8%)
1-3 167 (28.3%) 21 (23.6%) 135 (28.4%) 6 (31.6%) 0.09 95 (29.3%) 51 (28.8%) 0.18
4+ 55 (9.3%) 7 (7.9%) 44 (9.3%) 4 (21.1%) 26 (8.0%) 22 (12.4%)
Missing 2 0 1 1 1 1
Histologic grade
I 157 (26.6%) 22 (24.7%) 132 (27.8%) 3 (15.0%) 87 (26.9%) 48 (27.0%)
II 308 (52.1%) 47 (52.8%) 248 (52.2%) 11 (55.0%) 0.15 170 (52.5%) 91 (51.5%) 0.86
III 126 (21.3%) 20 (22.5%) 95 (20.0%) 6 (30.0%) 67 (20.7%) 39 (21.9%)
Missing 1 0 1 0 1 0
Hormone receptor status
ER+ 502 (86.7%) 76 (88.4%) 407 (87.2%) 15 (75.0%) 1df; 0.12 273 (85.8%) 153 (87.4%) 1df; 0.62
ER- 77 (13.3%) 10 (11.6%) 60 (12.8%) 5 (25.0%) 45 (14.2%) 22 (12.6%)
PgR+ 402 (69.4%) 61 (70.9%) 328 (70.2%) 9 (45.0%) 1df; 0.02 219 (68.9%) 122 (69.7%) 1df; 0.85
PgR- 177 (30.6%) 25 (29.1) 139 (29.8%) 11 (55.0%) 99 (31.1%) 53 (30.3%)
Missing 13 3 9 0 7 3
ER+ PgR+ 398 (68.7%) 60 (69.8%) 325 (69.6%) 9 (45.0%) 1df; 0.02 216 (67.9%) 122 (69.7%) 1df; 0.68
ER+ PgR- 104 (18.0%) 16 (18.6%) 82 (17.6%) 6 (30.0%) 1df; 0.16 57 (17.9%) 31 (17.7%) 1df; 0.95
ER- PgR+ 4 (0.7%) 1 (1.2%) 3 (0.6%) 0 1df; 0.72 3 (0.9%) 0 1df; 0.20
ER- PgR- 73 (12.6%) 9 (10.5%) 57 (12.2%) 5 (25.0%) 1df; 0.09 42 (13.2%) 22 (12.6%) 1df; 0.84















Table 4 Tumor characteristics in relation to self-reported milk production
Table 4 All patients Nulliparous Milk production of firstchild -Almost no milk
Milk production of first
child -Insufficient
Milk production of first
child -Adequate
Milk production of first
child -Excessive Ptrend
n=592 n=89 n=25 n=129 n=245 n=79
n (percent) n (percent) n (percent) n (percent) n (percent) n (percent)
pT 0.79
0 14 (2.4%) 3 (3.4%) 2 (8.0%) 2 (1.6%) 3 (1.2%) 1 (1.3%)
1 424 (71.6%) 61 (68.5%) 15 (60.0%) 89 (69.0%) 185 (75.5%) 57 (72.2%)
2 144 (24.3%) 23 (25.8%) 8 (32.0%) 36 (27.9%) 54 (22.0%) 19 (24.1%)
3 9 (1.5%) 2 (2.2%) 0 2 (1.6%) 3 (1.2%) 2 (2.5%)
4 1 (0.2%) 0 0 0 0 0
Number of axillary lymph nodes 0.14
0 368 (62.4%) 61 (68.5%) 18 (72.0%) 81 (62.8%) 151 (61.9%) 43 (55.1%)
1-3 167 (28.3%) 21 (23.6%) 4 (16.0%) 38 (29.5%) 72 (29.5%) 24 (30.8%)
4+ 55 (9.3%) 7 (7.9%) 3 (12.0%) 10 (7.8%) 21 (8.6%) 11 (14.1%)
Missing 2 0 0 0 1 1
Histologic grade 0.29
I 157 (26.6%) 22 (24.7%) 11 (44.0%) 31 (24.2%) 66 (26.9%) 23 (29.1%)
II 308 (52.1%) 47 (52.8%) 12 (48.0%) 73 (57.0%) 123 (50.2%) 39 (49.4%)
III 126 (21.3%) 20 (22.5%) 2 (8.0%) 24 (18.8%) 56 (22.9%)' 17 (21.5%)
Missing 1 0 0 1 0 0
Hormone receptor status
ER+ 502 (86.7%) 76 (88.4%) 22 (95.7%) 108 (84.4%) 207 (85.9%) 71 (91.0%) 0.68
ER- 77 (13.3%) 10 (11.6%) 1 (4.3%) 20 (15.6%) 34 (14.1%) 7 (9.0%)
PgR+ 402 (69.4%) 61 (70.9%) 18 (78.3%) 85 (66.4%) 162 (67.2%) 58 (74.4%) 0.70
PgR- 177 (30.6%) 25 (29.1) 5 (21.7%) 43 (33.6%) 79 (32.8%) 20 (25.6%)
Missing 13 3 2 1 4 1
ER+ PgR+ 398 (68.7%) 60 (69.8%) 18 (78.3%) 85 (66.4%) 159 (66.0%) 58 (74.4%) 0.76
ER+ PgR- 104 (18.0%) 16 (18.6%) 4 (17.4%) 23 (18.0%) 48 (19.9%) 13 (16.7%) 0.98
ER- PgR+ 4 (0.7%) 1 (1.2%) 0 0 3 (1.2%) 0 0.65
ER- PgR- 73 (12.6%) 9 (10.5%) 1 (4.3%) 20 (15.6%) 31 (12.9%) 7 (9.0%) 0.60
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Breast-feeding duration of the first child
b
≤12 months, n=  316      305      287      252       178       149       88        69         14       10








Figure 1 (See legend on next page.)
Gustbée et al. SpringerPlus 2013, 2:298 Page 10 of 15
http://www.springerplus.com/content/2/1/298
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Figure 1 Kaplan-Meier estimate of breast cancer-free survival in relation to breast-feeding duration. a. Kaplan-Meier estimate of breast
cancer-free survival in relation to breast-feeding duration of first child (P=0.001). The number of patients at each follow-up is indicated. Since this
is an ongoing study, the number of patients decreases with each follow-up. b. Kaplan-Meier estimate of breast cancer-free survival in relation to
total breast-feeding duration (P=0.008). The number of patients at each follow-up is indicated. Since this is an ongoing study, the number of
patients decreases with each follow-up.
Gustbée et al. SpringerPlus 2013, 2:298 Page 11 of 15
http://www.springerplus.com/content/2/1/298(Figure 1a) and total breast-feeding duration (Figure 1b).
Median follow-up time was 4.9 (interquartile range 3.0
to 6.4) years for all patients. Higher risk for early events
was seen in patients with over >12 months of breast-
feeding of the first child (Log-Rank P=0.001) and over >
12 months of total breast-feeding (Log-Rank P=0.008).
Breast-feeding of the first child > 12 months was associ-
ated with a three-fold increased risk for an early event
crude HR 3.54 (95% CI: 1.61-7.79) and remained signifi-
cant after adjustment for age, invasive tumor size (>20
mm or muscular or skin involvement), axillary lymph
node involvement, ER and PgR status, age at first birth,
time since last birth, smoking status, and BMI, type of
surgery, and treatment, adjusted HR 2.90 (95% CI: 1.22-
6.94). Total breast-feeding >12 months was associated
with a two-fold increased risk for an early event crude
HR 1.92 (1.18-3.14) and adjusted HR 1.96 (1.12-3.41).
Figures 2a and 2b illustrate the associations between milk
production during breast-feeding of the first child and risk
for early events. Greater milk production was associated
with higher risk for early events (Figure 2a; Log-Rank
Ptrend=0.011). Patients with almost no milk had no events.
‘Excessive milk production’ was associated with an over
two-fold increased risk for early breast cancer events com-
pared to patients with either adequate or insufficient milk
production as presented in Figure 2b (Log-Rank P=0.001)
crude HR 2.44 (1.39-4.30) and adjusted HR 2.54 (1.37-4.68).
‘Excessive milk production’ was associated with higher risk
for early events both in patients <50 years and ≥ 50 years at
diagnosis.
In a multivariable model including both ‘excessive milk
production’ and breast-feeding duration of the first child
>12 months, both were associated with a 2-fold risk for
early events, adjusted HRs 2.33 (1.25-4.36) and 2.39
(0.97-5.85), respectively. There was no interaction be-
tween long breast-feeding duration of the first child and
’excessive milk production’, neither in the crude analysis
nor in the multivariable model (both Ps≥0.54). However,
when including ‘excessive milk production’ and total
breast-feeding duration >12 months in the same model,
total breast-feeding duration was only borderline signifi-
cantly associated with risk for early events (P=0.14),
while the effect of milk production remained significant
(P=0.007).
‘Excessive milk production’ and breast-feeding dur-
ation of the first child >12 months, were bothassociated with shorter distant metastasis-free sur-
vival, adjusted HRs 2.59 (1.13-5.94) and 2.44 (0.82-
7.29), respectively. In the model including ‘excessive
milk production’ and total breast-feeding duration >12
months in the same model showed that patients with
‘excessive’ milk production had an over two-fold in-
creased risk for early distant metastases adjusted HR
2.88 (1.26-6.55), while total breast-feeding duration
>12 months was not associated with distant-
metastasis-free survival HR 1.32 (0.62-2.82).
Discussion
The main findings of this study were that breast cancer
patients who reported to have experienced ‘excessive
milk production’ while breast-feeding had an over two-
fold increased risk of an early breast cancer event as well
as distant metastasis. On the other hand, none of the
breast cancer patients in this study who had experienced
‘almost no milk production’ had a breast-cancer event.
To our knowledge this has not been shown in previous
studies. Longer breast-feeding duration of the first child
was also associated with higher risk for early events.
This finding could only in part be explained by the
amount of milk produced. Breast-feeding duration was
associated with ER/PgR status but not with other tumor
characteristics and milk production was not associated
with any of the tumor characteristics investigated.
Breast-feeding the first child for >12 months was asso-
ciated with a higher median age at first birth. Different
distributions of breast-feeding duration in relation to pa-
tient and tumor characteristics were also originally in-
vestigated. However, none of these distributions
contributed any further to the study and it was decided
to make the cut-off at 1-year, which is in line with other
studies (Collaborative Group on Hormonal Factors in
Breast Cancer 2002; Jernström et al. 2004). Ludvigsson
et al. reported that younger women tended to breast-
feed for a shorter period of time (Ludvigsson &
Ludvigsson 2005). Women who had a total breast-
feeding duration of >12 months were significantly less
often current smokers in the present study, which is in
line with other studies (Donath & Amir 2004;
Ludvigsson & Ludvigsson 2005). However, our study
only considered current smoking. Current smoking was
not significantly associated with milk production of the
first child, which was significantly correlated to breast-
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Figure 2 Kaplan-Meier estimate of breast cancer-free survival in relation to milk production. a. Kaplan-Meier estimate of breast cancer-free
survival in relation to four categories of milk production (P=0.011). The number of patients at each follow-up is indicated. Since this is an ongoing
study, the number of patients decreases with each follow-up. b. Kaplan-Meier estimate of breast cancer-free survival in relation to ‘excessive milk
production’ (P=0.001). In this figure ‘excessive milk production’ is compared to the three categories with lower milk production. The number of
patients at each follow-up is indicated. Since this is an ongoing study, the number of patients decreases with each follow-up.
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feeding duration. Accordingly, women with ‘excessive
milk production’ tended to breast-feed for a longer
period of time, which was expected, since an insufficient
amount of milk makes prolonged breast-feeding more
difficult (Gatti 2008; Thulier & Mercer 2009). Shorter
breast-feeding is associated with several socio-economic
factors including low maternal education (Ludvigsson &
Ludvigsson 2005). In the current study there was no
question regarding socioeconomic status. Low socioeco-
nomic status is associated with a decreased risk for
breast cancer (Granstrom et al. 2008), but an increased
risk for recurrence and death (Halmin et al. 2008). So-
cioeconomic status is therefore unlikely to explain why
patients who reported longer breast-feeding duration
and ‘excessive milk production’ had increased risk of
early events in the current study.
Breast-feeding duration, but not milk production, was
associated with ER and PgR status but not with other
tumor characteristics. In the current study, ER–/PgR–
tumors were non-significantly more common among
women who had breast-fed their first child for >12
months. However, there were only 20 women who had
breast-fed their first child for >12 months. Conversely,
two studies have found that triple negative breast tumors
were rare in patients with longer breast-feeding duration
(Redondo et al. 2012; Gaudet et al. 2011). However, the
study by Gaudet et al. only analyzed women 56 years
and younger, while the current study included patients
of all ages. Since Her2-status has only been routinely
evaluated since November 2005 in Lund (Lundin et al.
2011), it was not possible to investigate triple negativity
in relation to breast-feeding duration or milk production
in the current study.
Longer breast-feeding duration, both total and of the
first child, was associated with a higher risk for early
events. ‘Excessive milk production’ was the strongest fac-
tor of breast-feeding, affecting the risk for early events
as it was significant whether the model included breast-
feeding of the first child or total breast-feeding duration.
None of the investigated tumor criteria were associated
with milk production. However, it is possible that PRL
receptor or androgen receptor (AR) expression may dif-
fer as breast-feeding affects both prolactin and testoster-
one levels (Hietala et al. 2008; Nagata et al. 2011).
Ormandy et al. reported that the level of PRL receptor
expression in breast cancer cell lines was linearly relatedto that of the ER and PgR expression, but not to that of
the AR (Ormandy et al. 1997).
A cleaved fragment of prolactin called PRL 16K, which
is generated during breast-feeding, has been shown to
inhibit angiogenesis (Freeman et al. 2000; Goffin et al.
1999). Inhibited angiogenesis may result in more inva-
sive tumors and more metastases according to a recent
review (Leite de Oliveira et al. 2011). Longer breast-
feeding duration may thereby affect tumor characteris-
tics through impaired angiogenesis. However, no in-
creased axillary lymph node involvement was found
among tumors from patients with ‘excessive milk pro-
duction’. Angiogenesis in breast tumors is not routinely
analyzed in Sweden today.
We did not find any significant association between
milk production and tumor characteristics. However, the
finding of an increased risk of early breast cancer events
among the women with ‘excessive milk production’ may
indicate tumors with a higher proliferation rate. Further
analyzes, including milk production, PRL levels, AR ex-
pression, and proliferation rate (Ki67), need to be done
to verify this theory. Ki67 expression has been routinely
analyzed in Lund since March 2009 (Lundin et al. 2011).
Breast-feeding duration was not as strongly associated
with early events as we hypothesized. A recent larger co-
hort study from Norway reported that there was no evi-
dence for a dose-related effect of breast-feeding on
survival (Alsaker et al. 2011), but this study did not spe-
cifically look at breast-feeding duration of the first child.
Similar results were found in another smaller Swedish
retrospective study that only included long-term survi-
vors (Lööf-Johanson et al. 2011).
Between October 2002 and October 2008, 1139
women were registered with breast cancer at Skåne Uni-
versity Hospital in Lund, according to the Regional
Tumor Registry. In this study, 592 patients were in-
cluded. Most of the remaining women did not decline
participation in the study. Instead it was the lack of
available research nurses that limited the number of par-
ticipants. The women who did not participate in this
study had similar patient and tumor characteristics as
the ones who did participate (Lundin et al. 2011). There-
fore, we consider the material to be generalizable for the
women operated for breast cancer in Lund.
In Sweden, a very high proportion of women initiate
breast-feeding and almost all (97%) infants born in 2008
were breastfed at the age of one week (The National
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study results may be generalizable to the rest of Sweden,
but may not be generalizable to countries with different
breast-feeding practices. Since our study was a prospect-
ive cohort, we have been able to minimize several types
of bias. A retrospective study would not have caught the
short-term survivors, and therefore would have favored
patients with less aggressive cancer. All patients were in-
cluded in the study in a similar way; a few days prior to
surgery and before any events, minimizing the risk for
recall bias.
A study limitation is the fact that breast-feeding duration
and milk production were self-reported and that there was
no question with respect to why a woman stopped breast-
feeding. For some of the women, many years had passed
since they gave birth and there is a risk that they could have
forgotten for how long they breast-fed and how much milk
they produced. However, giving birth and breast-feeding are
very important events in a woman’s life. In Sweden, new
mothers who have too much milk are encouraged, during
postnatal follow-up, to sell their extra breast milk to the hos-
pital to feed premature babies, as long as the woman is
healthy and a non-smoker. Objective data on milk produc-
tion would be hard to come by given that it would involve
measuring breast milk production in a large cohort of
healthy women several decades prior to breast cancer diag-
nosis. Inaccurate reporting of breast-feeding duration and
milk production would have biased the results towards the
null hypothesis.
Milk production during breast-feeding may merit fur-
ther study to evaluate if it can be used as a prognostic
factor, since no correlation between milk production and
tumor characteristics was observed. Asking about
breast-feeding and milk production history is cheaper.
Markers, which would help to better tailor adjuvant
therapy to each patient are urgently needed. If the asso-
ciation between ‘excessive milk production’ and in-
creased risk for early events is confirmed in other breast
cancer populations, patients with ‘excessive milk produc-
tion’ may warrant more aggressive breast cancer therapy
and/or closer follow-up while patients who report al-
most no milk production while breast-feeding their first
child may warrant less aggressive treatment with fewer
side-effects. However, the median follow-up is currently
only five years and ER positive tumors tend to relapse
late (Osborne et al. 1980). Since breast-feeding is pro-
tective with respect to breast cancer incidence (Collab-
orative Group on Hormonal Factors in Breast Cancer
2002), we hypothesize that women who develop breast
cancer in spite of long breast-feeding may get especially
aggressive cancers, as shown in another South Swedish
cohort (Butt et al. 2010).
In conclusion, our finding that production of an ‘ex-
cessive’ amount of milk during breast-feeding increasesthe risk for early event highlights the potential import-
ance of milk production as a reproductive factor that
may affect breast cancer prognosis. This could poten-
tially lead to an adjusted way of asking about patient his-
tory, regarding reproductive factors for breast cancer
patients. Patients with an excessive milk production
seem to have a more aggressive type of breast cancer,
with higher risk for early breast cancer events. Therefore
they may need a different treatment than patients with
almost no milk production, among whom no early
events were observed.
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